Pharmafile Logo

Pepperl+Fuchs GB Limited

Pepperl+Fuchs is a leading developer and manufacturer of electronic sensors and components for the global automation market. Continuous innovation, enduring quality, and steady growth guarantees continued success, since more than 60 years. Pepperl+Fuchs employs 5,200 people worldwide and has manufacturing facilities in Germany, USA, Singapore, Hungary, Indonesia and Vietnam, most of them ISO 9001 certified.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

77 Ripponden Road, Oldham, Lancashire, OL1 4EL, United Kingdom
+44 (0)161 6336431

 Latest Content from PMHub 

Research Partnership wins prestigious 2023 BOBI Award

We are delighted to announce Research Partnership were announced the winners in the ‘Creative Fieldwork Team of the Year’ category at the BHBIA’s Best of Business Intelligence (BOBI) Awards.

Hidden Heroes – Account Manager’s half-marathon for Alzheimer’s Society

As a business, we place tremendous value in community and giving back. That's why we're so proud to share the charitable achievements of our team.

Going beyond the buzzword: omnichannel and healthcare marketing

The concept of omnichannel often gets confused with multichannel, with many pharma companies believing they are operating omnichannel when in fact it is a multichannel approach. In our latest blog,...

How to Increase Engagement During Virtual Events

Tip #4 - How do you plan the agenda for your virtual event? We suggest to invite participant input to build and personalize the engagement. Check out our full top...

Empowering Employees: Unleashing Potential for a Bright Future

We believe that true empowerment is not just giving a person a voice, but the freedom and ability to act.

[Free Case Study Booklet] Accelerating Patient Recruitment in a global rare disease trial

See how Innovative Trials supported a Top 5 pharma to complete enrollment in a Phase 2 Lupus study

Case study: How we provided in-depth knowledge of electrosurgical generators among target segments and settings in the US market

Find out how we helped our client to identify clinician roles and responsibilities, pain points and drivers and barriers with respect to a current medical device.

Research Partnership launches Access CGT

Research Partnership’s specialist market access team have launched Access CGT, a new syndicated access and policy tracker providing surveillance of the cell and gene therapy space.Read more

Innovation in Education Leads to Positive Outcomes at EAN 2023

The Medscape team recently returned from the 9th Annual Congress of the European Academy of Neurology (EAN) in Budapest, Hungary. Among the various highlights of the congress, the team showcased...

How Pharma, Payers, & Providers are Leveraging Patient Self-Management Platforms

Rick Anderson, President of DarioHealth, explores digital therapeutics, how DarioHealth is utilizing #ai and behavioral science to personalize each user’s health journey, and how this approach can help improve #diversity...